ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study.
<p><strong>INTRODUCTION:</strong> In this study (PRECISE), we assess the clinical utility of a germline DNA sequencing-based test (ToxNav) for mutations in DPYD and ENOSF1 genes to alter clinician-prescribed fluoropyrimidine doses and the use of a digital application (PROMinet) to...
Asıl Yazarlar: | Lee, L, Starkey, T, Sivakumar, S, Fotheringham, S, Mozolowski, G, Shearwood, V, Palles, C, Camilleri, P, Church, D, Kerr, R, Kerr, D |
---|---|
Materyal Türü: | Conference item |
Baskı/Yayın Bilgisi: |
Wiley
2019
|
Benzer Materyaller
-
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study
Yazar:: Lennard Y. W. Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01) -
'Toxgnostics': An unmet need in cancer medicine
Yazar:: Church, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
'Toxgnostics': an unmet need in cancer medicine.
Yazar:: Church, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
Yazar:: Ik Shin Chin, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01) -
DeepTox: Toxicity Prediction using Deep Learning
Yazar:: Andreas eMayr, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)